首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Biophysical characterization and immunization studies of dominant negative inhibitor (DNI) a candidate anthrax toxin subunit vaccine
【2h】

Biophysical characterization and immunization studies of dominant negative inhibitor (DNI) a candidate anthrax toxin subunit vaccine

机译:候选炭疽毒素亚单位疫苗显性负性抑制剂(DNI)的生物物理特性和免疫研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dominant negative inhibitor (DNI) is a translocation-deficient homolog of recombinant protective antigen of Bacillus anthracis that is a candidate for a next generation anthrax vaccine. This study demonstrates that the biophysical characteristics of the DNI protein stored in lyophilized form at 4 °C for 8 y were similar to recombinant protective antigen (rPA). To provide information on the accelerated stability of DNI, samples in the lyophilized form were subjected to thermal stress (40 and 70 °C for up to 4 weeks) and thoroughly evaluated using various biophysical and chemical characterization techniques. Results demonstrate preserved structural stability of the DNI protein under extreme conditions, suggesting long-term stability can be achieved for a vaccine that employs DNI, as desired for a biodefense countermeasure. Furthermore, the biological activity of the stressed DNI bound to the adjuvant Alhydrogel® was evaluated in mice and it was found that the immunogenicity DNI was not affected by thermal stress.
机译:显性阴性抑制剂(DNI)是炭疽芽孢杆菌重组保护性抗原的易位缺陷同源物,是下一代炭疽疫苗的候选者。这项研究表明,DNI蛋白的冻干形式在4°C下保存8 y的生物物理特性与重组保护性抗原(rPA)相似。为了提供有关DNI加速稳定性的信息,将冻干形式的样品置于热应力下(40和70°C长达4周),并使用各种生物物理和化学表征技术进行了全面评估。结果表明,在极端条件下,DNI蛋白的结构稳定性得以保留,这表明采用DNI的疫苗可以实现长期稳定性,这是生物防御对策所希望的。此外,在小鼠中评估了与佐剂Alhydrogel ®结合的应激DNI的生物学活性,发现免疫原性DNI不受热应激的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号